TherapeuticsMD, Inc. (TXMD) DCF Valuation

TherapeuticsMD, Inc. (TXMD) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

TherapeuticsMD, Inc. (TXMD) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify TherapeuticsMD, Inc. (TXMD) valuation with this customizable DCF Calculator! Featuring real TherapeuticsMD, Inc. (TXMD) financials and adjustable forecast inputs, you can test scenarios and uncover TherapeuticsMD, Inc. (TXMD) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 49.6 64.9 87.0 70.0 1.3 1.1 1.0 .9 .7 .6
Revenue Growth, % 0 30.67 34.03 -19.54 -98.14 -13.24 -13.24 -13.24 -13.24 -13.24
EBITDA -156.3 -149.5 -78.6 11.9 -8.4 -.8 -.7 -.6 -.6 -.5
EBITDA, % -314.84 -230.41 -90.36 16.95 -645.24 -74.68 -74.68 -74.68 -74.68 -74.68
Depreciation 2.5 5.5 .7 1.2 .1 .1 .0 .0 .0 .0
Depreciation, % 4.94 8.44 0.84645 1.71 9.37 5.06 5.06 5.06 5.06 5.06
EBIT -158.8 -154.9 -79.3 10.7 -8.5 -.8 -.7 -.6 -.6 -.5
EBIT, % -319.78 -238.84 -91.21 15.24 -654.61 -75.19 -75.19 -75.19 -75.19 -75.19
Total Cash 160.8 80.5 65.1 38.1 4.3 1.0 .8 .7 .6 .5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 24.4 32.4 36.2 .0 3.1
Account Receivables, % 49.14 49.92 41.61 0 237.33
Inventories 11.9 8.0 7.6 .0 .0 .1 .1 .1 .1 .1
Inventories, % 23.89 12.32 8.77 0 0 9 9 9 9 9
Accounts Payable 19.2 21.1 3.4 2.2 .0 .2 .2 .1 .1 .1
Accounts Payable, % 38.64 32.48 3.88 3.09 2.07 16.03 16.03 16.03 16.03 16.03
Capital Expenditure -23.9 -1.6 -2.2 -.4 .0 -.1 -.1 -.1 -.1 -.1
Capital Expenditure, % -48.12 -2.46 -2.56 -0.50741 0 -10.73 -10.73 -10.73 -10.73 -10.73
Tax Rate, % -32.76 -32.76 -32.76 -32.76 -32.76 -32.76 -32.76 -32.76 -32.76 -32.76
EBITAT -176.7 -179.6 -94.6 1,111.9 -11.3 -.8 -.7 -.6 -.6 -.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -215.2 -177.9 -117.2 1,155.4 -16.4 1.7 -.7 -.6 -.6 -.5
WACC, % 7.61 7.61 7.61 7.61 7.61 7.61 7.61 7.61 7.61 7.61
PV UFCF
SUM PV UFCF -.3
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 0
Terminal Value -14
Present Terminal Value -10
Enterprise Value -10
Net Debt 4
Equity Value -14
Diluted Shares Outstanding, MM 10
Equity Value Per Share -1.29

What You Will Get

  • Editable Forecast Inputs: Easily adjust key assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: TherapeuticsMD, Inc. (TXMD) financial data pre-filled to kickstart your evaluation.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that aligns with your valuation requirements.
  • Built for Analysts and Investors: Perfect for assessing projections, confirming strategies, and enhancing efficiency.

Key Features

  • Comprehensive Data: TherapeuticsMD’s historical financial statements and pre-filled projections.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Results: View TherapeuticsMD’s intrinsic value recalculating instantly.
  • Detailed Visual Outputs: Dashboard graphs present valuation results and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based TXMD DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
  3. Instant Calculations: The model automatically calculates TherapeuticsMD’s intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the results to inform your investment or financial analysis.

Why Choose This Calculator?

  • Accuracy: Utilizes real TherapeuticsMD financial data for precise calculations.
  • Flexibility: Allows users to easily adjust and experiment with input variables.
  • Time-Saving: Eliminate the need to create a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
  • User-Friendly: Intuitive design ensures accessibility for users without extensive financial modeling skills.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for analyzing TherapeuticsMD, Inc. (TXMD) stock.
  • Pharmaceutical Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the company.
  • Consultants and Advisors: Deliver precise valuation insights to clients regarding TherapeuticsMD, Inc. (TXMD).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech firms like TherapeuticsMD, Inc. (TXMD) are assessed in the market.

What the Template Contains

  • Pre-Filled DCF Model: TherapeuticsMD’s financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate TherapeuticsMD’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.